| Bioactivity | Anticancer agent 76 (Compound CT2-3) is an anticancer agent. Anticancer agent 76 significantly inhibits the proliferation of human NSCLC cells, induces cell cycle arrest, causes ROS generation and induces cell apoptosis[1]. |
| Invitro | Anticancer agent 76 (Compound CT2-3) (0-80 μM, 24 h) inhibits the proliferation of human NSCLC cells[1].Anticancer agent 76 (40 μM, 24 h) arrests cell cycle at G1 phase, induces apoptosis and ROS, suppresses the expression of c-Myc and topoisomerases in NSCLC cells [1]. Cell Proliferation Assay[1] Cell Line: |
| Name | Anticancer agent 76 |
| CAS | 2448091-11-8 |
| Formula | C32H33NO5S |
| Molar Mass | 543.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Anticancer agent 76
CAS: 2448091-11-8 F: C32H33NO5S W: 543.67
Anticancer agent 76 (Compound CT2-3) is an anticancer agent. Anticancer agent 76 significantly inhibits the proliferatio
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.